An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma

• Helen C.-H. He,

  Affiliation Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Lawrence Kashat,

  Affiliation Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Ipshita Kak,

  Affiliation Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Tada Kunavisarut,

  Affiliation Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Raefe Gundelach,

  Affiliations Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Department of Otolaryngology-Head and Neck Surgery Program, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Medicine, Endocrine Division of Mount Sinai Hospital and University of Toronto Medical School, Toronto, Ontario, Canada

  ⨯
• Dae Kim,

  Affiliations Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Department of Otolaryngology-Head and Neck Surgery Program, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Medicine, Endocrine Division of Mount Sinai Hospital and University of Toronto Medical School, Toronto, Ontario, Canada

  ⨯
• Anthony K.-C. So,

  Affiliation Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Christina MacMillan,

  Affiliation Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Jeremy L. Freeman,

  Affiliations Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Department of Otolaryngology-Head and Neck Surgery Program, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Medicine, Endocrine Division of Mount Sinai Hospital and University of Toronto Medical School, Toronto, Ontario, Canada

  ⨯
• Ranju Ralhan ,

  Contributed equally to this work with: Ranju Ralhan, Paul G. Walfish

  * E-mail: pwalfish@mtsinai.on.ca (PGW); rralhan@mtsinai.on.ca (RR)

  Affiliations Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada, Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Department of Otolaryngology-Head and Neck Surgery Program, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Paul G. Walfish

  Contributed equally to this work with: Ranju Ralhan, Paul G. Walfish

  * E-mail: pwalfish@mtsinai.on.ca (PGW); rralhan@mtsinai.on.ca (RR)

  Affiliations Alex and Simona Shnaider Laboratory in Molecular Oncology, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada, Joseph and Mildred Sonshine Family Centre for Head and Neck Diseases, Department of Otolaryngology-Head and Neck Surgery Program, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Medicine, Endocrine Division of Mount Sinai Hospital and University of Toronto Medical School, Toronto, Ontario, Canada, Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada, Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada

  ⨯